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Introduction
Obsessive–compulsive disorder (OCD) is a chronic neuro-
psychiatric disorder characterized by repetitive, intrusive 
and time-consuming thoughts (obsessions) and irresistible 
irrational behaviours or rituals (compulsions), which can 
cause severe distress to the patient.1 People with OCD often 
identify traumatic events and psychosocial stress as factors 
that develop and exacerbate their symptoms.2 In addition, 
cross-sectional case–control studies have shown oxidative 
imbalance3,4 and oxidative DNA damage5 in patients with 
OCD, suggesting that oxidative stress may play a crucial role 
in the pathophysiology of OCD. Although the effects of stress 
on the pathophysiology of OCD remain unclear, chronic 
stress may influence the underlying biochemical processes 
and neurobiological changes that occur in OCD.
Recently, the association of cellular aging with chronic 
stress and neuropsychiatric conditions has become a growing 
field of research. People with serious mental illnesses are 
prone to various physical health problems.6 Physical morbid-
ities such as cardiovascular and metabolic diseases were 
more prevalent in patients with psychiatric disorders than in 
the general population.7 Recent research has shown that 
OCD is associated with an increased risk of allergies and 
endocrine diseases.8,9 Such comorbidity for physical diseases 
and psychiatric disorders may be associated with accelerated 
cellular aging.10 However, few studies have investigated the 
role of cellular aging in OCD.
Accumulating evidence has shown that the shortening of 
telomere length in response to cumulative oxidative stress11,12 
is implicated in accelerated cellular aging and increased 
physical morbidity in neuropsychiatric conditions.13,14 As 
well, mitochondrial function has attracted much attention as 
a biomarker of stress adaptation and biological aging in 
chronic stress and psychiatric disorders.15 Mitochondria — 
highly dynamic organelles located in the cytosol of eukary-
otic cells — play a key role in cellular energy production and 
homeostasis by producing adenosine triphosphate through 
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Background: The present study examined whether mitochondrial DNA copy number (mtDNAcn) and telomere length — key markers of 
cellular aging — were altered in male and female participants with obsessive–compulsive disorder (OCD) compared to healthy controls. 
We also tested for associations between these alterations and OCD-related clinical features and inflammatory index. Methods: A total of 
235 patients with OCD (38.7% female) and 234 healthy controls (41.5% female) were included. We quantified whole-blood mtDNAcn 
and leukocyte telomere length using quantitative polymerase chain reaction. We also calculated the neutrophil-to-lymphocyte ratio from 
complete blood cell counts. Results: Multivariate analysis of covariance showed that OCD status had a significant overall effect on cellu-
lar aging markers in men (Wilks λ = 0.889, F2,275 = 17.13, p < 0.001) and women (Wilks λ = 0.742, F2,182 = 31.61, p < 0.001) after controlling 
for age, body mass index and childhood trauma. In post-hoc comparisons, men with OCD had lower mtDNAcn than controls (p < 0.001), 
but we found no between-group difference for telomere length (p = 0.55). Women with OCD had a significantly lower mtDNAcn (p < 
0.001) and shortened telomere length (p = 0.023) compared to controls. Moreover, the lower mtDNAcn shown in the OCD group was sig-
nificantly correlated with an increase in systemic inflammation for both sexes, as measured by neutrophil-to-lymphocyte ratio. Limitations: 
The present cross‐sectional design did not allow us to infer a causal relationship between OCD disease status and cellular aging markers. 
Conclusion: The present study is, to our knowledge, the first to demonstrate alterations in mtDNAcn and telomere shortening in OCD. 
These results suggest that aging-associated molecular mechanisms may be important in the pathophysiology of OCD.
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oxidative phosphorylation, and their fission and fusion 
processes help to facilitate adaptation to the changing en-
vironment in response to metabolic demand or stress.16 
 Altered mitochondrial DNA copy number (mtDNAcn), an 
index of mitochondrial dysfunction, has been associated 
with several psychiatric disorders, including posttraumatic 
stress disorder17 and bipolar disorder,18 although there 
have also been mixed findings of higher, reduced or un-
changed mtDNAcn in psychiatric disorders. To date, no 
study has investigated whether telomere shortening or 
alter ed mtDNAcn occur in OCD.
In the present study, we examined whether leukocyte 
telomere length and mtDNAcn were altered in male and fe-
male participants with OCD compared to healthy controls. 
We also tested whether these markers were associated with 
clinical and inflammatory factors of OCD. Given the role of 
stress and the possible involvement of oxidative stress in the 
pathogenesis of OCD, we hypothesized that participants 
with OCD would exhibit telomere shortening and altered 
mtDNAcn compared to healthy controls, and that the altera-
tions would be associated with clinical features and an in-
flammatory index of OCD.
Methods
Participants
A total of 243 patients with OCD (94 women) and 241 healthy 
controls (99 women) were included in the present study. The 
patients with OCD were recruited at an OCD-specialized 
outpatient clinic at Severance Hospital, Yonsei University 
Health System (Seoul, Republic of Korea). Healthy controls 
were recruited through advertisements. All participants were 
assessed by trained psychiatrists using the Structured Clinical 
Interview for the DSM-IV19 to evaluate them for the presence 
of current and previous psychiatric disorders. To be included 
in the OCD group, people had to be aged 19 to 50 years and 
have a primary diagnosis of OCD. A psychiatrist (S.J. Kim) 
confirmed the diagnosis based on the DSM-IV.19 Exclusion 
criteria were psychosis, bipolar disorder, substance depend-
ence, mental retardation as defined by the DSM-IV, head 
trauma, major somatic and neurologic disorders, pregnancy 
and breastfeeding. The ethnicity of all participants was self-
reported and only those who were ethnically Korean were 
enrolled. All participants provided written informed consent 
before participation, and this study was approved by the in-
stitutional review board of Severance Hospital, Yonsei Uni-
versity Health System.
Measurement of telomere length and mtDNAcn in blood
Genomic DNA was isolated from peripheral blood samples 
using a nucleic acid isolation device, the QuickGene-mini80 
(Fujifilm). Telomere length and mtDNAcn were then mea-
sured in the Blackburn Laboratory at the University of Califor-
nia, San Francisco. Telomere length (relative telomere to single 
copy gene ratio) was measured using quantitative poly-
merase chain reaction (qPCR) based on a method originally 
published by Cawthon.20 DNA samples were assayed twice 
in triplicate wells. If the difference between the 2 runs was 
greater than 7%, a third run was conducted and the average 
of the closest values was reported. The inter-assay coefficient 
of variation for telomere length was 2.1%. A detailed descrip-
tion of the assay procedures has been described previously.21
For mtDNAcn, the relative copy number of mtDNA per 
diploid nuclear genome was determined using a TaqMan 
multiplex assay. This involved the detection of a 69 bp frag-
ment of the ND1 gene in mtDNA (nucleotides 3485–3553) 
and an 87 bp fragment of RNase P (TaqMan Copy Number 
Reference Assay, human, RNase P; cat. no. 4403328; Life 
Technologies) in the nuclear genomic DNA, based on a previ-
ously published method.22 DNA samples were assayed in 
triplicate wells in a single run. A subset of samples was ran-
domly selected for a second run to obtain the inter-assay co-
efficient of variation, which was 4.1% for mtDNA. Details of 
the assay procedures have been previously described.17 All 
qPCR tests were performed using the LightCycler 480 Instru-
ment II (Roche Diagnostics).
Measures of clinical characteristics
The clinical symptoms of OCD were evaluated by a trained 
psychologist using the 10-item Yale–Brown Obsessive Com-
pulsive Scale23 for obsessive–compulsive symptom severity 
and the Montgomery–Åsberg Depression Rating Scale24 for 
depressive symptoms.
Age at onset of OCD was considered to be the age at which 
obsessive or compulsive symptoms first occurred as remem-
bered by patients or family members and was dichotomized 
as early-onset (≤ 17 years) and late-onset (> 17 years).25
Childhood traumatic experiences were assessed using the 
Early Trauma Inventory–Self-Report Short Form,26 which 
consists of 27 items in 4 different domains of childhood trau-
matic experiences: general trauma and physical, sexual and 
emotional abuse. The scores for all 4 domains are summed.
Measure of neutrophil-to-lymphocyte ratio as an 
 inflammatory marker
We analyzed the complete blood count with differential 
white blood cell count in a subset of the participants with 
OCD (n = 202) using the XN-20 (Sysmex). We calculated the 
neutrophil-to-lymphocyte ratio (NLR), an easily measured 
marker associated with systemic inflammation,27 from the 
complete blood count. Participants with a white blood cell 
count greater than 10 000 cells/μL (n = 18) or those with ex-
treme NLR outliers (n = 2) were excluded from our analyses.
Statistical analyses
We compared demographic and clinical characteristics be-
tween groups using independent-samples t tests for continu-
ous variables and Pearson χ2 tests for categorical variables. 
We calculated Pearson correlation (r) and partial correlation 
(pr) coefficients to examine relationships between the cellular 
markers and other variables. We performed multivariate 
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analysis of covariance (MANCOVA) and post-hoc compari-
sons using the 2 cellular markers as dependent variables and 
OCD status as an independent variable. Because lifespan and 
aging-related markers such as telomere length or attrition rate 
are affected by sex differences,28 we performed MANCOVAs 
in sex-stratified analyses to control for the possible effect of 
sex difference and reduce potential bias related to unmea-
sured interaction effects between sex and clinical features. In 
the partial correlation analysis and MANCOVAs, we con-
trolled for potential confounders (age, body mass index and 
childhood trauma) that have been associated with cellular 
 aging and oxidative stress.29,30 As well, to examine the relation-
ships between the 2 markers (telomere length and mtDNAcn) 
and clinical characteristics of OCD, we conducted hierarchical 
multiple linear regression analyses with 2 steps in each sex. In 
these analyses, we entered age, body mass index and child-
hood trauma as a block in the first step, and then 4 clinical 
characteristics (age at onset, duration of illness, Yale–Brown 
Obsessive Compulsive Scale score and Montgomery–Åsberg 
Depression Rating Scale score) as a second block in the next 
step. We analyzed all data using the Statistical Package for the 
Social Sciences, version 25.0 (SPSS Inc.). All tests were 2-tailed, 
and p < 0.025 was considered statistically significant based on 
Bonferroni correction for 2 dependent variables. Data values 
are presented as mean ± standard deviation.
Results
Sample characteristics
Of those who participated in the interview (243 patients with 
OCD and 241 controls), data from 8 patients and 7 controls 
were excluded from the final analysis: 7 controls had comor-
bid psychiatric disorders, 5 patients with OCD had incom-
plete self-reported data, 2 samples contained insufficient 
DNA, and 1 patient had an outlier telomere length value. The 
final analyses included 235 patients with OCD (91 women) 
and 234 healthy controls (97 women).
The mean ages for the OCD and control groups were 27.70 
± 7.55 years and 27.23 ± 7.72 years, respectively. We found no 
significant differences between the groups with respect to 
age, sex, education status or body mass index. Based on Early 
Trauma Inventory total scores, those in the OCD group had 
experienced more childhood trauma than those in the control 
group (p < 0.001; Table 1).
Demographic and psychosocial factors associated with 
 telomere length and mtDNAcn
In correlation analyses for the entire study population, age 
was inversely correlated with telomere length (r = −0.303, p < 
0.001), but was not significantly correlated with mtDNAcn 
(r  = −0.006, p = 0.89). Childhood trauma based on Early 
Trauma Inventory total score had a weak negative correlation 
with mtDNAcn (r = −0.094, p = 0.04) but not telomere length 
(r = −0.031, p = 0.50). As well, mtDNAcn was positively asso-
ciated with telomere length (r = 0.179, p < 0.001). When con-
trolling for age, body mass index and childhood trauma, the 
correlation between mtDNAcn and telomere length remained 
significant for the entire study population (pr = 0.182, p < 
0.001) and for the control and OCD groups (healthy controls 
pr = 0.153, p = 0.020; patients with OCD pr = 0.206, p = 0.002).
Among healthy controls, women exhibited higher telomere 
length (women 1.099 ± 0.225 v. men 1.043 ± 0.225, p = 0.04) 
and higher mtDNAcn (women 551.7 ± 103.1 v. men 519.5 ± 
119.5, p = 0.03) than men. Among patients with OCD, neither 
telomere length (women 1.030 ± 0.184 v. men 1.050 ± 0.225, 
p = 0.43) nor mtDNAcn (women 423.6 ± 124.5 v. men: 434.3 ± 
116.2, p = 0.51) was significantly different between women 
and men.
MANCOVA
MANCOVA using age, body mass index and childhood 
trauma as covariates showed that OCD status had a signifi-
cant overall effect on mtDNAcn and relative telomere 





(n = 234) t or χ2 p value
Age, yr 27.70 ± 7.55 27.23 ± 7.72 0.668 0.50
Education, high school/college or higher 126/109 123/111 0.052 0.82
Male/female 144/91 137/97 0.364 0.55
Body mass index, kg/m2 23.07 ± 2.79 22.87 ± 3.41 0.716 0.47
Early Trauma Inventory–Self-Report Short Form score 6.70 ± 4.77 4.19 ± 3.86 6.268 < 0.001
Yale–Brown Obsessive–Compulsive Scale score 25.79 ± 6.83 0.47 ± 1.87 54.63 < 0.001
Montgomery–Åsberg Depression Rating Scale score 20.54 ± 9.94 3.29 ± 3.95 24.72 < 0.001
Age at onset, yr 18.06 ± 7.30 —
Early onset/late onset 119/116 —
Duration of illness, yr 9.69 ± 6.74 —
Cellular aging markers
Relative telomere length 1.042 ± 0.185 1.066 ± 0.198 –1.357 0.18
Mitochondrial DNA copy number 430.12 ± 119.34 532.85 ± 113.88 –9.537 < 0.001
OCD = obsessive–compulsive disorder. Values are mean ± standard deviation or n.
*Of this group, 77 patients (45 men and 32 women) were drug-naive or had been drug-free for more than 8 weeks.
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length in both men (Wilks λ = 0.889, F2,275 = 17.13, p < 0.001) 
and women (Wilks λ = 0.742, F2,182 = 31.61, p < 0.001; Table 2). 
In post-hoc comparisons, male participants with OCD had a 
significantly reduced mtDNAcn compared to healthy con-
trols (p < 0.001), but we found no significant difference in 
relative telomere length between the 2 groups (p = 0.55). In 
contrast, female participants with OCD had a significantly 
reduced mtDNAcn (p < 0.001) and a shortened telomere 
length (p = 0.023) compared to healthy controls (Table 2 and 
Figure 1).
Medication in patients with OCD
Of the 144 men with OCD, 45 (31.3%) were drug-naive or 
had been drug-free for more than 8 weeks; the other 99 
(68.7%) had been prescribed serotonin reuptake inhibitors. 
Of the 91 women with OCD, 32 (35.2%) were drug-naive or 
drug-free for more than 8 weeks, and 59 (64.8%) were 
 taking serotonin reuptake inhibitors. We found no signifi-
cant difference between unmedicated and medicated pa-
tients with respect to telomere length (women 1.064 ± 0.204 
v. 1.012 ± 0.172, p = 0.20; men 1.072 ± 0.193 v. 1.039 ± 0.181, 
p = 0.33) or mtDNAcn (women 446.3 ± 120.6 v. 411.3 ± 
125.9, p = 0.20; men 430.5 ± 111.0 v. 436.0 ± 119.0, p = 0.33) 
in either sex.
Association between mtDNAcn and telomere length and 
clinical characteristics of OCD
Hierarchical multiple linear regression analyses showed no 
significant associations between mtDNAcn or telomere 
length and symptom severity of OCD, depressive symptoms, 
age at onset or duration of illness in participants with OCD of 
either sex.
Relationship of an inflammatory factor (NLR) with mtDNAcn 
and telomere length in men and women with OCD
In partial correlation analyses with covariates of age, body 
mass index and childhood trauma, we found a significant as-
sociation between NLR and mtDNAcn in both men and 
women with OCD (men [n = 115] pr = −0.330, p < 0.001; 
women [n = 67] pr = −0.519, p < 0.001). Figure 2 shows a scat-
terplot of raw scores for the 2 variables, which were inversely 
correlated in each sex. We found no significant association 
between NLR and telomere length for either sex.
Discussion
In the present study, we investigated whether leukocyte 
telomere length and whole-blood mtDNAcn were 
Table 2: MANCOVA of leukocyte telomere length and mitochondrial DNA copy number data from male and female OCD and control groups
Result
Men (n = 281)
p value










MANCOVA* Wilks λ = 0.889; F2,275 = 17.13 < 0.001 Wilks λ = 0.742; F2,182 = 31.61 < 0.001
Leukocyte telomere length 1.050 ± 0.185 1.043 ± 0.173 0.55 1.030 ± 0.184 1.099 ± 0.225 0.023
Mitochondrial DNA copy number 434.25 ± 116.19 519.49 ± 119.48 < 0.001 423.58 ± 124.54 551.73 ± 103.14 < 0.001
MANCOVA = multivariate analysis of covariance; OCD = obsessive–compulsive disorder.
*With age, body mass index and childhood trauma as covariates.
Figure 1: Relative leukocyte telomere length and whole blood mitochondrial DNA copy number for male and female patients with OCD and healthy 
controls. *p < 0.05. Error bars represent ± 2 standard errors of the mean. OCD = obsessive–compulsive disorder; SEM = standard error of the mean. 
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 associated with OCD in a relatively homogeneous Korean 
population. To the best of our knowledge, this was the first 
study to investigate the role of telomere length and 
 mtDNAcn in the pathophysiology of OCD. We demon-
strated significantly reduced telomere length and mtDNAcn 
in female participants with OCD compared to healthy con-
trols. Male participants with OCD also had a significantly 
reduced mtDNAcn compared to healthy controls, but we 
found no significant difference in telomere length between 
the 2 groups. These results suggest the possible involve-
ment of mitochondrial dysfunction and telomere erosion in 
the pathophysiology of OCD.
We demonstrated a reduction in mtDNAcn in both male 
and female participants with OCD. The mtDNAcn in the 
present OCD sample showed no significant associations 
with clinical variables such as duration of illness or Yale–
Brown Obsessive Compulsive Scale, possibly because of a 
lack of statistical power to detect an association; another 
possible explanation is that mtDNAcn may be a predispos-
ing factor for OCD rather than a state factor of clinical fea-
tures. Although little is known about whether OCD is associ-
ated with altered mtDNAcn, there has been indirect evidence 
of mitochondrial involvement in OCD. Occurrence of OCD 
has been reported in cases with mitochondrial disease.31 In 
addition, genetic variants associated with mitochondrial 
disease have been identified in patients with OCD.32 Al-
though the underlying mechanisms linking mitochondrial 
dysfunction to OCD are unclear, a growing body of evidence 
suggests that the role of mitochondria in cellular stress re-
sponses and regulation of energy metabolism and homeo-
stasis may be important in pathophysiological changes of 
the brain to stress.33 Notably, mitochondria are principal 
hubs in the regulation of immune and inflammatory re-
sponses.34 A study in Taiwanese, community-dwelling older 
adults showed that low mtDNAcn was associated with 
high inflammatory markers.35 Similarly, the reduction in 
mtDNAcn shown in the OCD group from the present study 
was significantly correlated with an increase in systemic in-
flammation as measured by the NLR. It has been suggested 
that cumulative damage to mitochondria and mtDNA induced 
by reactive oxygen species affects inflammatory responses 
and cellular senescence.36 In turn, inflammatory stress leads 
to enhanced reactive oxygen species production and cumu-
lative damage to mtDNA, and the interplay between oxida-
tive stress and mitochondrial dysfunction can result in en-
ergy failure, biological aging and the pathogenesis of 
age-related diseases.37,38 Thus, interplay between reduced 
mtDNAcn and elevated inflammation might contribute to 
the development of OCD.
On the other hand, mtDNAcn was not correlated with age 
in our sample, which consisted mostly of young adults. Al-
though there has been some evidence showing an age-related 
decline in mtDNAcn,39–41 several reports (including our find-
ings) have found no association between mtDNAcn and 
Figure 2: Association between neutrophil-to-lymphocyte ratio and mitochondrial DNA copy number. Using original raw data 
without adjusting for covariates, the scatterplot shows an inverse relationship for both sexes.




































E456 J Psychiatry Neurosci 2021;46(4)
age.42–44 This inconsistency in findings may be because of dif-
ferent age groups used and a narrow age range among par-
ticipants. Findings from previous literature of age-related de-
cline in mtDNAcn was observed for participants older than 
50 years.39,45 In addition, although mtDNAcn quantification 
has been used as a biomarker for mitochondrial function and 
has been implicated in age-related diseases,46 it is not a direct 
measure of the functionality of individual mitochondria and 
may reflect oxidative stress states rather than cellular aging 
itself.44,47 Indeed, mtDNAcn as measured by qPCR, which re-
flects the relative quantity of mitochondrial DNA compared 
to the nuclear DNA in a sample, should be considered a 
proxy for the content of mitochondrial copies. Mixed findings 
have been also reported with respect to the direction of al-
tered mtDNAcn in several neuropsychiatric disorders. One 
study showed a significant reduction in mtDNAcn in combat-
related posttraumatic stress disorder and an “inverted-U” re-
lationship between mtDNAcn and symptom severity of post-
traumatic stress disorder.17 In contrast, increased mtDNAcn 
has been reported in patients with attention-deficit/ 
hyperactivity disorder48 and major depression,49 and was as-
sociated with childhood trauma and lifetime psychopathol-
ogy,50 suggesting that an increase in mtDNAcn might be a 
compensatory cellular response to mitochondrial dysfunc-
tion.51 Interestingly, a meta-analysis of mtDNAcn studies in 
bipolar disorder revealed no association between bipolar dis-
order and alterations in mtDNAcn, but Asian populations 
with bipolar disorder showed significantly reduced 
 mtDNAcn compared to controls.18 This observed discrepancy 
in results might be related to differences among studies in 
methods for extracting DNA and measuring mtDNAcn. Fur-
ther research using a reliable measure of mitochondrial func-
tion and oxidative stress is needed to determine the involve-
ment of mitochondrial dysfunction and cellular aging in 
neuropsychiatric diseases such as OCD.
After controlling for age, body mass index and childhood 
trauma, female participants with OCD exhibited significantly 
shorter telomere length compared to healthy controls. Al-
though there is little direct evidence of altered telomere length 
in OCD, some indirect evidence supports an association be-
tween telomere shortening and OCD. Increased oxidative 
stress and oxidative imbalance have been implicated in the 
pathophysiology of OCD,32,52,53 and it is well established that 
oxidative stress is associated with shortened telomere length.14 
Furthermore, increased oxidative DNA damage has been 
noted in OCD,54 which is known to induce telomere attrition.55 
In this study, we observed telomere shortening in female, but 
not male, patients with OCD, possibly because women are 
more vulnerable to OCD-associated telomere erosion or be-
cause of potential differences in clinical features between men 
and women. Because the findings from sex-stratified analyses 
cannot clarify the contribution of sex to the cellular aging pro-
cess, future research is needed to help determine the role of 
sex in telomere biology and mitochondrial function, and their 
different associations with psychiatric disorders.
Although the mechanisms linking cellular aging markers 
to OCD remain to be elucidated, it is unlikely that mitochon-
drial dysfunction and telomere erosion affect OCD patho-
genesis via independent pathways. There is emerging evi-
dence that these are linked biologically and have a 
complicated telomere–mitochondrial relationship during 
the human aging process.56 Consistent with the findings of 
this study, leukocyte telomere shortening and mtDNAcn 
have been positively intercorrelated in healthy individ-
uals57,58 and in pregnant women,59 suggesting coregulation of 
telomere biology and mitochondrial function.58 Telomere 
dysfunction is known to reciprocally affect altered mito-
chondrial biogenesis.60 In addition, both oxidative stress and 
telomere erosion may be induced by mitochondrial dysfunc-
tion in response to stress.61 Although the underlying mech-
anisms are not well understood, elevated stress and pro-
inflammatory cytokines may induce both mitochondrial 
dysfunction and altered telomere biology.15 Further research 
elucidating the complicated telomere–mitochondrial rela-
tionship and its underlying mechanisms is required.
Limitations
In the present study, we measured mtDNAcn and telomere 
length in peripheral blood, and not in brain tissue. It is un-
clear whether peripheral biomarkers reflect brain status in 
neuropsychiatric disorders. Notably, a postmortem study 
found that people who had died by suicide had a higher 
mtDNAcn in peripheral blood but a lower mtDNAcn in the 
prefrontal cortex compared to controls.62 Shorter telomere 
length was also identified in both the peripheral blood and 
prefrontal cortex of the same people, showing an opposite re-
lationship between telomere length and mtDNAcn in post-
mortem blood and brain tissue. However, whether these 
 peripheral biomarkers accurately reflect neuronal biomarkers 
remains unclear, and this is a methodological limitation of 
human research involving clinical populations.
The present study had other limitations. First, the cross‐
sectional design did not allow us to infer a causal relation-
ship between OCD disease status and cellular aging markers. 
Second, we controlled for the possible effects of age, child-
hood trauma and body mass index, but did not consider 
other potential confounders that may affect oxidative stress, 
such as recent stressors, smoking, exercise and nutrition. 
Third, we did not assess other potentially related biomarkers 
such as oxidative stress markers and telomerase activity. 
Fourth, we measured only cellular mtDNAcn in leukocytes 
and did not detect circulating mtDNA levels in cell-free 
plasma, which may be released into the circulation by the 
 mitochondria under stress.63 In addition, although we found 
no significant relationship between platelet counts and 
mtDNAcn among participants with OCD (data not shown), 
mtDNAcn measured using the extracted genomic DNA from 
whole blood can be affected by mtDNA in platelets.64 Finally, 
although the results of the present study did not show a sig-
nificant effect of medication status on mtDNAcn or telomere 
length, psychotropic drug treatments may affect cellular 
 aging. The influence of psychotropic medications on mito-
chondrial processes has been investigated mainly using ani-
mal studies and thus remains unclear.65 Future longitudinal 
studies including larger samples of drug-naive patients with 
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OCD are needed to confirm the present findings and eluci-
date the role of mitochondrial dysfunction in the pathophysi-
ology of OCD.
Conclusion
The present study is the first to demonstrate alterations in 
mtDNAcn in OCD. We also identified telomere shortening in 
women with OCD. Our results suggest that aging-associated 
molecular mechanisms may be important in the pathophysi-
ology of OCD. Future studies involving larger cohorts are 
warranted to investigate the role of mitochondrial dysfunc-
tion and telomere length in OCD and elucidate the molecular 
mechanisms that underlie OCD-related pathophysiology.
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